Back to ListMeet the 3billion Team at ACMG 2026
From March 10–14, 3billion will attend the annual meeting of the American College of Medical Geneticists (ACMG) in Baltimore, Maryland.
During the conference, 3billion will present its clinical variant interpretation software, GEBRA.
GEBRA is designed to support laboratories performing WES and WGS analysis. While many tools focus primarily on variant prioritization, GEBRA emphasizes what comes next in the interpretation workflow. The platform helps clinicians organize evidence, follow ACMG-based evaluation processes, and conduct structured reviews within a traceable framework.
By bringing interpretation logic into a single system, GEBRA reduces cognitive burden for reviewers and supports consistent decision-making across teams and over time—allowing experts to focus more on thoughtful clinical interpretation.
The 3billion team looks forward to connecting with healthcare professionals and researchers at ACMG 2026.
Visit us at booth #516 to learn more.
Get exclusive rare disease updates
from 3billion.
3billion Inc.
3billion is dedicated to creating a world where patients with rare diseases are not neglected in diagnosis and treatment.
